拜瑞妥利伐沙班片多少钱一盒

(Rivaroxaban) is a small molecule oral anticoagulant jointly developed by Bayer and Johnson & Johnson. On September 15 and October 1, 2008, Xarelto Rivaroxaban tablets were approved for marketing in Canada and the European Union respectively. Rivaroxaban tablets were approved for marketing by the State Food and Drug Administration in March 2009. On July 1, 2011, Xarelto Rivaroxaban tablets were approved by the FDA. The drug is used to prevent deep vein thrombosis in patients undergoing knee or hip replacement surgery.

The indications of Xarelto Rivaroxaban Tablets include: 1. For the prevention of venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. 2. Used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT. 3. For use in adult patients with nonvalvular atrial fibrillation who have one or more risk factors (e.g., congestive heart failure, hypertension, age ≥75 years, diabetes, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism.

How much does a box of Xarelto Rivaroxaban tablets cost?

Price in the United States: Strength: 10mg-10 tablets/box, pharmacy price: US$156.24; Strength: 15mg-30 tablets/box, pharmacy price: US$438.67; Strength: 20mg-30 tablets/box, pharmacy price: US$553.65.

The price of Xarelto rivaroxaban tablets produced by Bayer in Germany is in Turkey. The specification is 20mg*28 tablets, and the price of a box is about 350$; the specification is 15mg*28 tablets, and the price of a box is about 350$.

Recommended related hot articles: /newsDetail/81582.html